Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

CTRE vs GMRE vs SBRA vs CHCT vs WELL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CTRE
CareTrust REIT, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$8.82B
5Y Perf.+112.1%
GMRE
Global Medical REIT Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$94M
5Y Perf.-35.4%
SBRA
Sabra Health Care REIT, Inc.

REIT - Healthcare Facilities

Real EstateNASDAQ • US
Market Cap$5.19B
5Y Perf.+52.9%
CHCT
Community Healthcare Trust Incorporated

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$505M
5Y Perf.-51.5%
WELL
Welltower Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$149.25B
5Y Perf.+320.4%

CTRE vs GMRE vs SBRA vs CHCT vs WELL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CTRE logoCTRE
GMRE logoGMRE
SBRA logoSBRA
CHCT logoCHCT
WELL logoWELL
IndustryREIT - Healthcare FacilitiesREIT - Healthcare FacilitiesREIT - Healthcare FacilitiesREIT - Healthcare FacilitiesREIT - Healthcare Facilities
Market Cap$8.82B$94M$5.19B$505M$149.25B
Revenue (TTM)$468M$148M$813M$122M$11.63B
Net Income (TTM)$335M$2M$156M$6M$1.43B
Gross Margin86.8%68.8%63.5%62.8%39.1%
Operating Margin69.1%24.9%29.0%31.3%4.4%
Forward P/E26.6x595.7x29.8x37.6x78.4x
Total Debt$894M$654M$2.55B$536M$21.38B
Cash & Equiv.$198M$7M$72M$3M$5.03B

CTRE vs GMRE vs SBRA vs CHCT vs WELLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CTRE
GMRE
SBRA
CHCT
WELL
StockMay 20May 26Return
CareTrust REIT, Inc. (CTRE)100212.1+112.1%
Global Medical REIT… (GMRE)10064.6-35.4%
Sabra Health Care R… (SBRA)100152.9+52.9%
Community Healthcar… (CHCT)10048.5-51.5%
Welltower Inc. (WELL)100420.4+320.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: CTRE vs GMRE vs SBRA vs CHCT vs WELL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CTRE leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Welltower Inc. is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. GMRE also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
CTRE
CareTrust REIT, Inc.
The Real Estate Income Play

CTRE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 108.8%, EPS growth 96.3%, 3Y rev CAGR 36.5%
  • 265.1% 10Y total return vs GMRE's 308.1%
  • 108.8% FFO/revenue growth vs GMRE's -1.8%
  • Lower P/E (26.6x vs 78.4x)
Best for: growth exposure and long-term compounding
GMRE
Global Medical REIT Inc.
The Real Estate Income Play

GMRE ranks third and is worth considering specifically for income & stability.

  • Dividend streak 5 yrs, beta 0.48, yield 63.5%
  • 63.5% yield, 5-year raise streak, vs CHCT's 11.3%
Best for: income & stability
SBRA
Sabra Health Care REIT, Inc.
The REIT Holding

SBRA lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: real estate exposure
CHCT
Community Healthcare Trust Incorporated
The REIT Holding

Among these 5 stocks, CHCT doesn't own a clear edge in any measured category.

Best for: real estate exposure
WELL
Welltower Inc.
The Real Estate Income Play

WELL is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.

  • Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
  • Beta 0.13, yield 1.3%, current ratio 5.34x
  • Beta 0.13 vs CHCT's 0.60, lower leverage
  • +42.7% vs GMRE's +0.1%
Best for: sleep-well-at-night and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthCTRE logoCTRE108.8% FFO/revenue growth vs GMRE's -1.8%
ValueCTRE logoCTRELower P/E (26.6x vs 78.4x)
Quality / MarginsCTRE logoCTRE71.5% margin vs GMRE's 1.7%
Stability / SafetyWELL logoWELLBeta 0.13 vs CHCT's 0.60, lower leverage
DividendsGMRE logoGMRE63.5% yield, 5-year raise streak, vs CHCT's 11.3%
Momentum (1Y)WELL logoWELL+42.7% vs GMRE's +0.1%
Efficiency (ROA)CTRE logoCTRE6.7% ROA vs GMRE's 0.2%, ROIC 6.1% vs 2.0%

CTRE vs GMRE vs SBRA vs CHCT vs WELL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CTRECareTrust REIT, Inc.
FY 2025
Reportable Segment
100.0%$476M
GMREGlobal Medical REIT Inc.

Segment breakdown not available.

SBRASabra Health Care REIT, Inc.
FY 2025
Health Care, Resident Service, Ancillary Service
100.0%$5M
CHCTCommunity Healthcare Trust Incorporated
FY 2018
Real Estate
100.0%$6M
WELLWelltower Inc.
FY 2025
Senior Housing - Operating
81.1%$8.5B
Triple Net
11.4%$1.2B
Outpatient Medical
7.5%$782M

CTRE vs GMRE vs SBRA vs CHCT vs WELL — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCTRELAGGINGCHCT

Income & Cash Flow (Last 12 Months)

CTRE leads this category, winning 5 of 6 comparable metrics.

WELL is the larger business by revenue, generating $11.6B annually — 95.0x CHCT's $122M. CTRE is the more profitable business, keeping 71.5% of every revenue dollar as net income compared to GMRE's 1.7%. On growth, CTRE holds the edge at +99.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…SBRA logoSBRASabra Health Care…CHCT logoCHCTCommunity Healthc…WELL logoWELLWelltower Inc.
RevenueTrailing 12 months$468M$148M$813M$122M$11.6B
EBITDAEarnings before interest/tax$428M$95M$432M$82M$2.8B
Net IncomeAfter-tax profit$335M$2M$156M$6M$1.4B
Free Cash FlowCash after capex$400M$19M$367M$60M$2.5B
Gross MarginGross profit ÷ Revenue+86.8%+68.8%+63.5%+62.8%+39.1%
Operating MarginEBIT ÷ Revenue+69.1%+24.9%+29.0%+31.3%+4.4%
Net MarginNet income ÷ Revenue+71.5%+1.7%+19.2%+5.0%+12.3%
FCF MarginFCF ÷ Revenue+85.5%+12.6%+45.1%+49.4%+21.9%
Rev. Growth (YoY)Latest quarter vs prior year+99.3%+18.7%+20.8%+4.8%+40.3%
EPS Growth (YoY)Latest quarter vs prior year+2.9%-166.2%-5.9%+124.4%+22.5%
CTRE leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

GMRE leads this category, winning 3 of 6 comparable metrics.

At 25.2x trailing earnings, CTRE trades at a 89% valuation discount to CHCT's 228.4x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than WELL's 66.4x.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…SBRA logoSBRASabra Health Care…CHCT logoCHCTCommunity Healthc…WELL logoWELLWelltower Inc.
Market CapShares × price$8.8B$94M$5.2B$505M$149.2B
Enterprise ValueMkt cap + debt − cash$9.5B$741M$7.7B$1.0B$165.6B
Trailing P/EPrice ÷ TTM EPS25.17x115.29x32.16x228.42x153.25x
Forward P/EPrice ÷ next-FY EPS est.26.58x595.67x29.83x37.62x78.42x
PEG RatioP/E ÷ EPS growth rate1.19x
EV / EBITDAEnterprise value multiple23.03x8.35x17.01x16.27x66.40x
Price / SalesMarket cap ÷ Revenue18.51x0.68x6.70x4.17x13.99x
Price / BookPrice ÷ Book value/share2.00x0.17x1.78x1.11x3.35x
Price / FCFMarket cap ÷ FCF23.27x14.89x8.95x52.41x
GMRE leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

CTRE leads this category, winning 6 of 9 comparable metrics.

CTRE delivers a 8.6% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $0 for GMRE. CTRE carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHCT's 1.25x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs GMRE's 4/9, reflecting strong financial health.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…SBRA logoSBRASabra Health Care…CHCT logoCHCTCommunity Healthc…WELL logoWELLWelltower Inc.
ROE (TTM)Return on equity+8.6%+0.5%+5.6%+1.4%+3.5%
ROA (TTM)Return on assets+6.7%+0.2%+2.8%+0.6%+2.3%
ROICReturn on invested capital+6.1%+2.0%+3.8%+1.6%+0.5%
ROCEReturn on capital employed+7.7%+5.3%+5.2%+2.8%+0.6%
Piotroski ScoreFundamental quality 0–954557
Debt / EquityFinancial leverage0.22x1.18x0.90x1.25x0.49x
Net DebtTotal debt minus cash$696M$647M$2.5B$533M$16.3B
Cash & Equiv.Liquid assets$198M$7M$72M$3M$5.0B
Total DebtShort + long-term debt$894M$654M$2.6B$536M$21.4B
Interest CoverageEBIT ÷ Interest expense8.44x1.14x2.40x1.15x0.26x
CTRE leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

WELL leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $5,441 for CHCT. Over the past 12 months, WELL leads with a +42.7% total return vs GMRE's +0.1%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs CHCT's -13.9% — a key indicator of consistent wealth creation.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…SBRA logoSBRASabra Health Care…CHCT logoCHCTCommunity Healthc…WELL logoWELLWelltower Inc.
YTD ReturnYear-to-date+9.9%+6.9%+9.0%+11.2%+14.3%
1-Year ReturnPast 12 months+40.3%+0.1%+20.5%+14.5%+42.7%
3-Year ReturnCumulative with dividends+117.8%+5.6%+113.0%-36.1%+189.5%
5-Year ReturnCumulative with dividends+96.6%-21.4%+49.9%-45.6%+202.3%
10-Year ReturnCumulative with dividends+265.1%+308.1%+50.9%+83.9%+223.1%
CAGR (3Y)Annualised 3-year return+29.6%+1.8%+28.7%-13.9%+42.5%
WELL leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

SBRA leads this category, winning 2 of 2 comparable metrics.

SBRA is the less volatile stock with a -0.06 beta — it tends to amplify market swings less than CHCT's 0.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBRA currently trades 97.7% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…SBRA logoSBRASabra Health Care…CHCT logoCHCTCommunity Healthc…WELL logoWELLWelltower Inc.
Beta (5Y)Sensitivity to S&P 5000.14x0.48x-0.06x0.60x0.13x
52-Week HighHighest price in past year$41.72$39.93$21.07$18.22$219.59
52-Week LowLowest price in past year$27.72$29.05$17.08$13.23$142.65
% of 52W HighCurrent price vs 52-week peak+94.7%+89.5%+97.7%+97.0%+97.0%
RSI (14)Momentum oscillator 0–10054.552.754.556.960.2
Avg Volume (50D)Average daily shares traded2.5M130K2.1M228K2.6M
SBRA leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.

Analyst consensus: CTRE as "Buy", GMRE as "Buy", SBRA as "Hold", CHCT as "Hold", WELL as "Buy". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs 3.0% for SBRA (target: $21). For income investors, GMRE offers the higher dividend yield at 63.51% vs WELL's 1.30%.

MetricCTRE logoCTRECareTrust REIT, I…GMRE logoGMREGlobal Medical RE…SBRA logoSBRASabra Health Care…CHCT logoCHCTCommunity Healthc…WELL logoWELLWelltower Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyHoldHoldBuy
Price TargetConsensus 12-month target$42.50$40.00$21.20$18.50$226.50
# AnalystsCovering analysts1922291634
Dividend YieldAnnual dividend ÷ price+3.2%+63.5%+5.8%+11.3%+1.3%
Dividend StreakConsecutive years of raises250112
Dividend / ShareAnnual DPS$1.27$22.70$1.18$2.00$2.76
Buyback YieldShare repurchases ÷ mkt cap+0.0%0.0%0.0%+0.4%0.0%
Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.
Key Takeaway

CTRE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GMRE leads in 1 (Valuation Metrics). 1 tied.

Best OverallCareTrust REIT, Inc. (CTRE)Leads 2 of 6 categories
Loading custom metrics...

CTRE vs GMRE vs SBRA vs CHCT vs WELL: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CTRE or GMRE or SBRA or CHCT or WELL a better buy right now?

For growth investors, CareTrust REIT, Inc.

(CTRE) is the stronger pick with 108. 8% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). CareTrust REIT, Inc. (CTRE) offers the better valuation at 25. 2x trailing P/E (26. 6x forward), making it the more compelling value choice. Analysts rate CareTrust REIT, Inc. (CTRE) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CTRE or GMRE or SBRA or CHCT or WELL?

On trailing P/E, CareTrust REIT, Inc.

(CTRE) is the cheapest at 25. 2x versus Community Healthcare Trust Incorporated at 228. 4x. On forward P/E, CareTrust REIT, Inc. is actually cheaper at 26. 6x.

03

Which is the better long-term investment — CTRE or GMRE or SBRA or CHCT or WELL?

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to -45. 6% for Community Healthcare Trust Incorporated (CHCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus SBRA's +50. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CTRE or GMRE or SBRA or CHCT or WELL?

By beta (market sensitivity over 5 years), Sabra Health Care REIT, Inc.

(SBRA) is the lower-risk stock at -0. 06β versus Community Healthcare Trust Incorporated's 0. 60β — meaning CHCT is approximately -1024% more volatile than SBRA relative to the S&P 500. On balance sheet safety, CareTrust REIT, Inc. (CTRE) carries a lower debt/equity ratio of 22% versus 125% for Community Healthcare Trust Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — CTRE or GMRE or SBRA or CHCT or WELL?

By revenue growth (latest reported year), CareTrust REIT, Inc.

(CTRE) is pulling ahead at 108. 8% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Community Healthcare Trust Incorporated grew EPS 133. 7% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, CTRE leads at 36. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CTRE or GMRE or SBRA or CHCT or WELL?

CareTrust REIT, Inc.

(CTRE) is the more profitable company, earning 67. 3% net margin versus 4. 2% for Community Healthcare Trust Incorporated — meaning it keeps 67. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 67. 2% versus 3. 3% for WELL. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CTRE or GMRE or SBRA or CHCT or WELL more undervalued right now?

On forward earnings alone, CareTrust REIT, Inc.

(CTRE) trades at 26. 6x forward P/E versus 595. 7x for Global Medical REIT Inc. — 569. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.

08

Which pays a better dividend — CTRE or GMRE or SBRA or CHCT or WELL?

All stocks in this comparison pay dividends.

Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 1. 3% for Welltower Inc. (WELL).

09

Is CTRE or GMRE or SBRA or CHCT or WELL better for a retirement portfolio?

For long-horizon retirement investors, Sabra Health Care REIT, Inc.

(SBRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 06), 5. 8% yield). Both have compounded well over 10 years (SBRA: +50. 9%, CHCT: +83. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CTRE and GMRE and SBRA and CHCT and WELL?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CTRE is a small-cap high-growth stock; GMRE is a small-cap income-oriented stock; SBRA is a small-cap income-oriented stock; CHCT is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CTRE

High-Growth Quality Leader

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 49%
  • Net Margin > 42%
Run This Screen
Stocks Like

GMRE

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 41%
Run This Screen
Stocks Like

SBRA

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 10%
  • Net Margin > 11%
Run This Screen
Stocks Like

CHCT

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Gross Margin > 37%
  • Dividend Yield > 4.5%
Run This Screen
Stocks Like

WELL

High-Growth Compounder

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CTRE and GMRE and SBRA and CHCT and WELL on the metrics below

Revenue Growth>
%
(CTRE: 99.3% · GMRE: 18.7%)
P/E Ratio<
x
(CTRE: 25.2x · GMRE: 115.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.